Ascendis Pharma

Organisation

Trials

NCT01947907
Phase 2, Completed, 53 people, 23 Sept 2013

Named in competing interests

LDL-C target attainment and treatment costs in high-risk and very-high-risk patients with or without bempedoic acid: A Spanish cohort simulation
Fees or honoraria, 14 Aug 2026

Sources: pubmed.ncbi.nlm.nih.gov

Papers

Visceral Adiposity Does Not Explain Increased Rates of Diabetes among Asian, Black, and Hispanic Individuals—A Cross-Sectional Analysis of NHANES 2011-2018
ADA Scientific Sessions 2025 abstract, 13 Jun 2025